Transfection of Multidrug Resistant Gene into Human Hematopoietic Stem Cells and its Clinical Application in Bone Marrow Transplantation
Transfection of Multidrug Resistant Gene into Human Hematopoietic Stem Cells and its Clinical Application in Bone Marrow Transplantation
批准号:
01480299
负责人:
OHNO Ryuzo
金额:
$0.7万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990
中文摘要
多药耐药基因(MDR1)编码一种膜结合p糖蛋白(分子量约为170 kDa),在结构无关的细胞毒性药物如长春花生物碱、蒽环类药物、秋水仙碱、放线菌素D等药物的外排转运中起重要作用,其中一些药物目前已被临床用于癌症化疗。最近,MDR1基因的分离为在分子水平上阐明癌细胞的多药耐药带来了希望。我们的目标是将MDR1基因引入人造血干细胞,以获得具有多药耐药表型的正常血细胞。从单核细胞白血病细胞系NOMO1/ADR cDNA文库中克隆出MDR1 cDNA片段,全长4.3 kb。该cDNA已插入逆转录病毒载体pCO1中。将该载体转染到包装细胞系PA-12中产生病毒。该病毒赋予犬肾细胞系MDCK多重耐药表型。通过单克隆抗体的筛选和分选方案,从正常骨髓中获得了20 - 30个浓度的人多能干细胞。将含有MDR1 cDNA的病毒感染这些细胞。用含药培养基培养的菌落数量没有增加。观察存活菌落中活细胞的增加。初步分析了新表达系统的潜在用途。在产生细胞中完成了病毒滴度的50次扩增。然而,也发现了病毒基因组的大量缺失,这表明基因缺陷可能是由快速基因复制引起的。
英文摘要
Multidrug Resistant gene (MDR1) encodes a membrane-binding P-glycoprotein (approximately 170 kDa molecular mass) that plays an important role in efflux transportation of structurally unrelated cytotoxic drugs such as Vinca alkaloids, anthracycline, colchicine, actinomycin D and some other drugs, some of which are now clinically used in cancer chemotherapy.Recently, isolation of the gene for MDR1 has raised hope that multidrug resistance of cancer cells might be elucidated at a molecular level.We aimed to introduce MDR1 gene into human hematopoietic stem cells to obtain otherwise normal blood cells with a multidrug resistant phenotype.MDR1 cDNA fragment (4.3 kb in length) was cloned from cDNA library derived from monoblastic leukemia cell line, NOMO1/ADR. This cDNA has been inserted into a retroviral vector pCO1. Virus was produced after transfection of this vector into a packaging cell line PA-12. This virus conferred multidrug resistant phenotype on dog kidney cell line MDCK.Twenty to 30-hold concentration of human multipotent stem cells from normal bone marrow was achieved by panning and sorting protocol with monoclonal antibodies. Virus containing MDR1 cDNA was infected into these cells. There is no increase in the number of colonies cultured with drug-containing medium. Increment of viable cells in surviving colonies was observed.We preliminarily analyzed a potential use of new expression system. Fifty-hold amplification of virus titer was accomplished in the producer cells. However, a large deletion of viral genome was also identified, suggesting that the gene defect might be caused by a rapid gene duplication.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ryuzo Ohno.: "Recent progress in the treatment of adult acute leukemia" Acta Haematologica Japonica. 52. 1287-1293 (1989)
Ryuzo Ohno.:“成人急性白血病治疗的最新进展”Acta Haematologica Japonica。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshinori Ito, et al.: "Increased P-glycoprotein expression and multidrung-resistant gene (mdr1) amplification are infrequently found in fesh acute leukemia cells : sequential analysis of 15 cases at initial presentation and relapsed stage." Cancer. 63 :.
Yoshinori Ito 等人:“在急性急性白血病细胞中很少发现 P-糖蛋白表达增加和多药耐药基因 (mdr1) 扩增:对 15 例初发和复发阶段的病例进行序贯分析。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshinori Ito,et al.: "Increased Pーglycoprotein expression and multidrugーresistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells: sequential analysis of 15 cases at intial presentation and relapsed stage." Cancer. 63. 1534
Yoshinori Ito 等人:“新鲜急性白血病细胞中很少发现 P 糖蛋白表达增加和多药耐药基因 (mdr1) 扩增:对 15 例初发和复发阶段的病例进行连续分析 63. 1534。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ryuzo Ohno, et al.: "Intensive induction therapy with behenoyl cytosine arabinoside, daunorubicin, and 6-mercaptopurine follwed by intensive consolidation with mitoxantrone, Etoposide, vincristine, and intermediate-dosecontinuous cytarabine (M-85 Protocol
Ryuzo Ohno 等人:“使用山嵛酰胞嘧啶阿糖苷、柔红霉素和 6-巯基嘌呤进行强化诱导治疗,然后使用米托蒽醌、依托泊苷、长春新碱和中剂量连续阿糖胞苷强化巩固治疗(M-85 方案)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ryuzo Ohno: "Recent Progness in the treatment of adult acute levkemia." Acta Haewatol Jpn.52. 1287-1293 (1989)
Ryuzo Ohno:“成人急性白血病治疗的最新进展。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Pedestrians' Mental State and Path Choice at Urban Intersections and Relevant Environmental Information
-
批准号:23360265
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.57万
-
财政年份:2011
-
负责人:OHNO Ryuzo
-
依托单位:
Influence of Information and Architectural Space on Evacuation Decision-making in Case of Emergency
-
批准号:20560566
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2008
-
负责人:OHNO Ryuzo
-
依托单位:
Effect of Wording of Fire Warning Announcements on Evacuation Behavior in Subway Stations
-
批准号:18560593
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.25万
-
财政年份:2006
-
负责人:OHNO Ryuzo
-
依托单位:
A study on perception of ambient visual information while moving
-
批准号:16560535
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2004
-
负责人:OHNO Ryuzo
-
依托单位:
The Effectiveness of design guideline regulations for improving streetscape
-
批准号:14550605
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:OHNO Ryuzo
-
依托单位:
Influence of Movable Elements on Environment Cognition and Behavior
-
批准号:10450219
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.55万
-
财政年份:1998
-
负责人:OHNO Ryuzo
-
依托单位:
Collaborative study for the best treatment of acute leukemia.
-
批准号:08044265
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.1万
-
财政年份:1996
-
负责人:OHNO Ryuzo
-
依托单位:
Cytokine receptor expression and gene in myelodysplastic syndromes.
-
批准号:07457230
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1995
-
负责人:OHNO Ryuzo
-
依托单位:
Differentiation therapy of acute promylocytic leukemia.
-
批准号:05044157
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.88万
-
财政年份:1993
-
负责人:OHNO Ryuzo
-
依托单位:
Description Method for Unattended Ambient information and its phychological impacts
-
批准号:02805074
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1990
-
负责人:OHNO Ryuzo
-
依托单位:
Investigation on a cooperative development of stratergy on curative treatment of leukemia with Federal Republic of Germany
-
批准号:02042003
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.56万
-
财政年份:1990
-
负责人:OHNO Ryuzo
-
依托单位:
Analysis of genes involved in proliferation and differentiation of megakaryopoiesis using a human megakaryoblastic leukemia cell line
-
批准号:62480261
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.62万
-
财政年份:1987
-
负责人:OHNO Ryuzo
-
依托单位:
Differentiation of a human megaryoblastic cell line (MEG-01) and its production of platelets and platelet-derived factors
-
批准号:60480281
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.18万
-
财政年份:1985
-
负责人:OHNO Ryuzo
-
依托单位:
海外基金